Get started
Author

Shan‐Liang Sun

Structural Analysis of Chemokine Receptor–Ligand Interactions
2017 · Marta Arimont, Shan-Liang Sun, et al. · Journal of Medicinal Chemistry · 125
Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia
2020 · Yue Zhong, Run-Ze Qiu, et al. · Journal of Medicinal Chemistry · 89
Overcoming cancer therapy resistance: From drug innovation to therapeutics
2025 · Jin-Rui Wei, Meng-Yi Lu, et al. · Drug Resistance Updates · 44
Natural products as potential lead compounds to develop new antiviral drugs over the past decade
2023 · Jing-Han Zhao, Yue-Wei Wang, et al. · European Journal of Medicinal Chemistry · 43
Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance
2022 · Shan-Liang Sun, Shi-Han Wu, et al. · Journal of Medicinal Chemistry · 43
GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway
2024 · Xiaolin Sun, Chaorui Guo, et al. · Redox Biology · 35
NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway
2022 · Yuanjiao Zhang, Zhendong Deng, et al. · Frontiers in Oncology · 34
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
2022 · Chunyan Gu, Yajun Wang, et al. · Journal of Experimental & Clinical Cancer Research · 32
PDF
Non-coding RNAs as therapeutic targets in cancer and its clinical application
2024 · Xuejiao Leng, Mengyuan Zhang, et al. · Journal of Pharmaceutical Analysis · 29
GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer
2023 · Chao Tang, Mengying Ke, et al. · Advanced Science · 28
PDF
Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
2011 · Shuai Lu, Hai-Chun Liu, et al. · International Journal of Molecular Sciences · 24
PDF
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
2024 · Tian‐Hua Wei, Meng‐Yi Lu, et al. · MedComm – Oncology · 22
PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway
2024 · Zhendong Deng, Shanliang Sun, et al. · Advanced Science · 20
An efficient strategy for digging protein-protein interactions for rational drug design - A case study with HIF-1α/VHL
2021 · Xin Xue, Ji-Bo Kang, et al. · European Journal of Medicinal Chemistry · 19
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists
2018 · I. Adlere, S. Sun, et al. · European Journal of Medicinal Chemistry · 19
PDF
A toolbox of molecular photoswitches to modulate the CXCR3 chemokine receptor with light
2019 · Xavier Gómez-Santacana, Sabrina M de Munnik, et al. · Beilstein Journal of Organic Chemistry · 18
PDF
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations
2024 · Zi-Xuan Wang, Qing-Qing Li, et al. · Journal of Medicinal Chemistry · 17
Exploring the landscape of post-translational modification in drug discovery
2024 · Yuhao Cao, Tianyi Yu, et al. · Pharmacology & Therapeutics · 15
Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies
2023 · Xin-Zhuo Zhan, Tian-Hua Wei, et al. · Journal of Ethnopharmacology · 15
Tomentosin suppressed M1 polarization via increasing MERTK activation mediated by regulation of GAS6
2023 · Yu-xi Di, Yu-jie Bao, et al. · Journal of Ethnopharmacology · 14
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
2024 · Tian-Hua Wei, Zi-Xuan Wang, et al. · Journal of Medicinal Chemistry · 13
Functional polymorphisms in microRNAs and susceptibility to liver cancer: a meta-analysis and meta-regression
2014 · B.S. Wang, Z. Liu, et al. · Genetics and Molecular Research · 13
PDF
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia
2022 · Ji-Bo Kang, Lu Chen, et al. · Bioorganic & Medicinal Chemistry · 11
Luteolin inhibits diffuse large B-cell lymphoma cell growth through the JAK2/STAT3 signaling pathway
2025 · Xin-Zhuo Zhan, Yi-Wen Bo, et al. · Frontiers in Pharmacology · 10
PDF
SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27
2025 · Ling Wang, Jie Min, et al. · Acta Pharmaceutica Sinica B · 10
Works count: 66
Citation count: 834
H-index: 17
I10-index: 25
Year
Topic
Type